Purchase Order 68HE0B21P0064
- Not listed
- This federal contract award, valued at $34,376.60, was issued by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Bioivt, LLC, a for-profit limited liability company based in Westbury, New York. The contract is for the procurement of 27 vials of cryopreserved hepatocytes, which are specialized biological specimens used in scientific research and medical advancement. The contract award is not designated as a set-aside and was competitively awarded. Bioivt,...
- The U.S. Environmental Protection Agency (EPA) Office of Research and Development awarded a firm fixed price purchase order to Biospyder Technologies, Inc. (doing business as Biospyder), a for-profit small business manufacturer, to provide analysis of additional tissues from PFAS rat studies. The $248,885.00 contract supports Biospyder's Tempo-Seq targeted gene expression analysis services to assess transcriptomic impacts resulting from chemical exposures. This work aligns with the EPA's...
- This federal contract award, valued at $28,290.26, was issued by the U.S. Environmental Protection Agency's Office of Research and Development to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation specializing in toxicology pathology services. The contract is for analysis and reporting of histology and pathology of rodent tissues following exposure to per- and polyfluoroalkyl substances (PFAS) in multiple samples of adult livers and kidneys, as well as pop...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bioivt, LLC for the purchase of cryopreserved hepatocytes. The contract has a ceiling value of $16,179.20 and a completion date of August 16, 2024. Bioivt, LLC is a leading global provider of high-quality biological specimens and value-added services, with experience delivering similar products to federal agencies including the Defense Health Agency, Army Medical Command, National Institutes of Health,...
- The Environmental Protection Agency awarded a $32,390 firm fixed price purchase order to Experimental Pathology Laboratories, Inc., doing business as EPL, for histology and pathology services of rodent tissues from perfluoroalkyl and polyfluoroalkyl substances (PFAS) studies. EPL will perform the requested histology and pathology work on rodent tissue samples from the EPA Office of Research and Development's PFAS program studies. The work will be conducted at EPL's Sterling, Virginia facility...
- The Environmental Protection Agency's Office of Research and Development awarded a $242,000 firm-fixed-price purchase order to Burleson Research Technologies, Inc., a for-profit subchapter S corporation, to conduct in vivo mouse assays for a lead bioavailability study. This work is being performed under an existing indefinite delivery contract held by Burleson with EPA, valued at $4.25 million, for scientific and technical support services related to lead bioavailability assessments. The...
- The U.S. Environmental Protection Agency's Office of Research and Development awarded a $23,858.55 purchase order to Waters Technologies Corporation for PFAS (per- and polyfluoroalkyl substances) supplies on December 9, 2025, with completion targeted for January 30, 2026. This firm fixed-price contract was awarded without a competitive set-aside and represents a direct replacement parts procurement under a sole-source justification. Waters, headquartered in Milford, Massachusetts, will perform...
- This is a firm fixed-price purchase order contract awarded by the Office of Research and Development within the U.S. Environmental Protection Agency to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract is for RNA sequencing of mouse brain tissue (choroid plexus) following exposure to per- and polyfluoroalkyl substances (PFAS). The contract has a ceiling value of $14,173.08 and a period of performance through January 31, 2025. No...
- The Environmental Protection Agency has awarded a $16,568.85 purchase order to Biocrates Life Sciences AG for metabolomics assay kits. The firm fixed price contract is being carried out under the agency's Office of Research and Development's BAA exemption and will provide supplies to support EPA's research programs. Work will be performed in Durham, North Carolina through December 2023. No major subcontractors or set aside designations were identified. This award will deliver laboratory products...
- This is a firm fixed price delivery order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to ICF Incorporated, L.L.C. under the contract 68HERC19D0003. The award is for $2,156,595.00 to provide laboratory support for repeated dose oral toxicity studies of per- and polyfluoroalkyl substances (PFAS) in rats. This work supports the EPA's Human Health Risk Assessment (HHRA) program. The award has a performance period through April 30, 2025. There is...
The Environmental Protection Agency Office of Research and Development awarded a $165,120.00 firm fixed price purchase order to Bioivt, LLC, a for-profit limited liability company, to assay a set of approximately 80-120 per- and polyfluoroalkyl substances (PFAS) for activity across a suite of in vitro transporter targets. The contract has two optional years. Bioivt, a leading global provider of high quality biological specimens and related services, has previously delivered biological materials such as cryopreserved and cryoplateable hepatocytes, plasma, serum, and urine to support medical research programs across federal agencies including the Defense Health Agency, Army Medical Command, National Institutes of Health, Food and Drug Administration, and Centers for Disease Control and Prevention. Bioivt holds a $1 billion Blanket Purchase Agreement with the National Institutes of Health and a $3.5 million Indefinite Delivery Contract with the Army Medical Command to provide various biological materials.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
In Vitro Transporter Substrate Screening | 68HE0B21Q0032 | Environmental Protection Agency Office of Research and Development | Solicitation 1/1 | 10/21/20, 6:08 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | ($41k) | 3/14/23 | |
| P00003 | Exercise an Option | $41.3k | 9/19/22 | |
| P00002 | Other Administrative Action | ($41k) | 4/13/22 | |
| P00001 | Exercise an Option | $41.3k | 10/21/21 | |
| Not listed | Not listed | $165.1k | 11/3/20 |